Perez Rafael L, Kimani Anthony P, King Talmadge E, Aguayo Samuel M, Roman Jesse
Pulmonary Division, Department of Medicine, Emory University, Atlanta Veterans Affairs Medical Center, Atlanta, Ga 30033, USA.
Respiration. 2007;74(3):297-303. doi: 10.1159/000091994. Epub 2006 Mar 9.
Abnormalities of lung coagulation and fibrinolysis in sarcoidosis are thought to play a role in the pathogenesis of this disease.
We previously showed that bronchoalveolar lavage fluid (BALF) D dimer directly correlated with various measures of severity in sarcoidosis. Here, we analyze our observation that BALF D dimer was more frequently found at higher levels in African-American patients with pulmonary sarcoidosis.
BALF D dimer was measured in 55 subjects with pulmonary sarcoidosis and 31 healthy volunteers by enzyme immunoassay. The healthy group established a normal range of BALF D dimer with 71 ng/ml as the highest measured level. This was the cut point for comparisons among the patients with sarcoidosis.
High BALF D dimer levels (>71 ng/ml) were found in younger patients with sarcoidosis and were associated with a significantly lower percent predicted forced expiratory volume in 1 s and greater numbers of BAL lymphocytes. Black patients with sarcoidosis had higher BALF D dimer levels (median 131, range 0-2,040 ng/ml) than white patients (median 18, range 0-605 ng/ml; p = 0.011). Higher than normal BALF D dimer levels were found in 61% of the black subjects with sarcoidosis, but in only 20% of the white individuals (chi(2) = 5.539, p = 0.019). BALF D dimer was the only disease measure that discriminated black from white individuals with sarcoidosis.
BALF D dimer is an indicator of lung fibrin formation and degradation in sarcoidosis. The relationship of high D dimer levels with greater BAL lymphocytosis and worse lung function may be a marker of active sarcoidosis, especially in African-Americans who tend to suffer a more serious form of the disease.
结节病患者肺凝血和纤溶异常被认为在该疾病的发病机制中起作用。
我们之前发现支气管肺泡灌洗液(BALF)D-二聚体与结节病的各种严重程度指标直接相关。在此,我们分析了我们的观察结果,即患有肺部结节病的非裔美国患者中,BALF D-二聚体水平较高更为常见。
通过酶免疫测定法测量了55例肺部结节病患者和31名健康志愿者的BALF D-二聚体。健康组确定了BALF D-二聚体的正常范围,最高测量水平为71 ng/ml。这是结节病患者之间进行比较的切点。
在较年轻的结节病患者中发现BALF D-二聚体水平较高(>71 ng/ml),并且与1秒用力呼气量预测值百分比显著降低以及BAL淋巴细胞数量增加有关。结节病黑人患者的BALF D-二聚体水平(中位数131,范围0 - 2,040 ng/ml)高于白人患者(中位数18,范围0 - 605 ng/ml;p = 0.011)。61%的结节病黑人受试者BALF D-二聚体水平高于正常,但白人个体中仅为20%(χ² = 5.539,p = 0.019)。BALF D-二聚体是区分结节病黑人和白人个体的唯一疾病指标。
BALF D-二聚体是结节病患者肺纤维蛋白形成和降解的指标。高D-二聚体水平与更高的BAL淋巴细胞增多症和更差的肺功能之间的关系可能是活动性结节病的一个标志,尤其是在倾向于患更严重形式疾病的非裔美国人中。